NHWD-870

N/A

Report date: 2024/02/04 17:47:54
NME

Base Information

Drug NameNHWD-870
Drug Alias NameNHWD-870
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsSkin MelanomaSolid tumoursNUT midline carcinoma +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNingbo Wenda Pharma
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNingbo Wenda Pharmaceutical Technology Co LtdHunan Hengya Pharmaceutical Technology Co LtdNingbo Wenda Pharma
Inactive CompaniesN/A
Active IndicationsSkin MelanomaSolid tumoursNUT midline carcinoma +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A